DV
Dividend Vision

HRMY — Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc. (HRMY)

Total return is 3.0% over the past 6 years, 147.0 points behind SPY at 150.0%. Its deepest 1-year drawdown was 34.5%.

HRMY is an equity holding in Harmony Biosciences, a pharmaceutical company, rather than a diversified ETF with a defined investment strategy or distribution policy. The holding does not currently report a dividend yield, distribution frequency, or expense ratio, indicating it functions as a single-stock position rather than a fund with ongoing income distributions. This holding may appeal to investors seeking exposure to the biopharmaceutical sector, though it lacks the diversification and structured income characteristics typical of dividend-focused ETFs.

HRMY key facts

Asset type
Stock
Asset class
Equity
Inception date
08/19/2020
Distribution frequency
None
Last close
$38.12
Market cap
$2,219,971,328
Average volume
388600.0
Beta
0.913
Payout ratio
0.0
P/E ratio
12.3366
Forward P/E
10.6383
EPS
$3.09